Genome Diagnostics

What Genome Diagnostics does

Genome Diagnostics B.V., operating as GenDx, is a Netherlands-based molecular diagnostics company founded in 2005 and headquartered in Utrecht, with a US subsidiary in San Diego. The company specializes in NGS-based reagents and analysis software for transplantation diagnostics, including high-resolution HLA typing, post-transplant chimerism monitoring, KIR genotyping, and MICA/MICB typing. Its core product portfolio comprises the NGSgo assay family (NGSgo-MX6-1, NGSgo-MX11-3, NGSgo-AmpX), the NGSengine analysis software, custom laboratory services, and companion diagnostics programs that integrate with pharmaceutical clinical trials. GenDx also operates the GenDx Academy, an online HLA learning platform launched in June 2026 for customer training and education.

GenDx sells to HLA laboratories, transplant centers, and pharmaceutical sponsors through a hybrid direct-sales and global distributor model, generating revenue from reagent and kit sales (hardware-style), software licensing (recurring), contract laboratory services, and companion diagnostics development. The product stack is supported by an unusually broad regulatory footprint — ISO 13485:2016, EU IVDR QMS with CE marking across seven product codes, MDSAP for Canada and Brazil, Korean GMP, and Health Canada Medical Device Licenses for both assays and software — which functions as a material barrier to entry in regulated transplant diagnostics markets.

The company is a specialized subsidiary of Eurobio Scientific Group, a diversified diagnostics conglomerate, and operates with a headcount in the 51-100 range. Its customer base includes large academic medical centers and national health systems (e.g., Atrium Wake Forest Baptist, University Health Network Toronto, NHS, Integrated BioBank of Luxembourg), and the company emphasizes world-class technical support, customer education through GenDx Academy, and continuous product development as core differentiators in a niche clinical market.

Name

Genome Diagnostics

Legal name

Genome Diagnostics B.V.

Website

https://gendx.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

51–100 employees

Short description

GenDx (Genome Diagnostics B.V.) is a Netherlands-based molecular diagnostics company that develops NGS-based reagents, kits, and analysis software for HLA typing, chimerism monitoring, and immunogenetics, serving HLA laboratories, transplant centers, and pharmaceutical partners globally. It is a subsidiary of Eurobio Scientific Group.

Ownership category

akta.pro rank

Product category

Transplant Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)

akta.pro primary industry

Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)

akta.pro secondary industries

Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Companion Diagnostic (CDx) Co-Development Services (biopharma partnerships, clinical strategy) (HLAAAMAB)

Keywords

• HLA typing reagents
• Transplant diagnostics
• Molecular diagnostics kits
• Chimerism monitoring
• Companion diagnostics

Headquarters

HQ city

Utrecht

HQ country

Netherlands

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Molecular Diagnostic Products: Sale of reagents, kits, and consumables for HLA typing, chimerism monitoring, and related immunogenetics testing performed in customer laboratories.
2. Analysis Software Licenses: Licensing of software packages for data analysis, interpretation, and reporting of genetic testing results.
3. Custom Laboratory Services: Contract laboratory services providing specialized testing capabilities for customers without in-house capacity.
4. Companion Diagnostics: Co-development and provision of diagnostic tests alongside pharmaceutical partners for companion diagnostic applications.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels8 records

Core offering

GenDx develops, manufactures, and sells NGS-based molecular diagnostic kits and reagents (NGSgo product line) for HLA typing, chimerism monitoring, KIR typing, and MICA/MICB typing used in transplantation workflows. The reagents are bundled with NGSengine, the company's proprietary analysis software, and complemented by Custom Lab Services for contract testing and Companion Diagnostics programs supporting clinical trials and personalized medicine.

Product overview

GenDx operates as a science-based molecular diagnostics company specializing in transplantation healthcare, offering an integrated portfolio of NGS-based laboratory reagents and companion software products. The core offering consists of HLA Typing products (including NGSgo-MX6-1, NGSgo-MX11-3, and NGSgo-AmpX kits), Chimerism Monitoring reagents, KIR Typing, and MICA/MICB Typing products—all paired with the proprietary NGSengine analysis software. Beyond reagents, GenDx provides Custom Lab Services for contract testing and Companion Diagnostics programs supporting clinical trials. The company recently launched GenDx Academy as an online educational platform complementing its product portfolio.

Differentiator

Problem solved

Functional benefit

Brands

• GenDx Academy: Dedicated online HLA learning platform for GenDx customers offering product trainings, case studies, and educational resources.

Products and services

• NGS HLA Typing Products

Quantifiable outcome

• 87% of office-based employees commute by bicycle, walking, or public transport (sustainability metric)

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• Eurobio Scientific GroupcoreOthersEurobio Scientific Group is the parent company of GenDx, providing corporate ownership and strategic resources while allowing GenDx to operate as a specialized subsidiary focused on transplant diagnostics.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• CareDx: CareDx is a transplant-focused diagnostics company offering testing services and products across pre- and post-transplant care. It overlaps with GenDx in transplant-related molecular diagnostics and chimerism monitoring.
• Immucor: Immucor provides transfusion and transplantation diagnostics, including HLA typing reagents and instruments. It competes with GenDx in HLA-related immunogenetics products for transplant and immunohematology labs.
• One Lambda (Thermo Fisher Scientific): One Lambda, now part of Thermo Fisher Scientific, is the market-leading provider of HLA typing reagents and software for transplantation. It is the most direct competitor to GenDx in NGS-based HLA typing and transplant immunogenetics.
• Linkage Biosciences: Linkage Biosciences offers HLA typing and chimerism monitoring products based on real-time PCR and NGS. It competes with GenDx's NGS chimerism monitoring and HLA typing reagent portfolio.
• Inno-Train Diagnostik: Inno-Train Diagnostik develops HLA typing and chimerism reagents using SSO and NGS methodologies. It is a comparable niche competitor to GenDx in transplant immunogenetics reagents.
• Histogenetics: Histogenetics is a specialized HLA typing laboratory services provider using NGS for high-resolution typing. It competes with GenDx's NGS HLA typing reagents and custom lab services for transplant matching workflows.
• Omixon: Omixon develops NGS-based HLA typing kits and software for transplantation diagnostics. It directly competes with GenDx in NGS HLA reagents and analysis software for clinical and research HLA labs.
• BAG Health Care (BAG Diagnostics): BAG Health Care provides molecular diagnostics for HLA typing and transplant immunology. It competes with GenDx in supplying HLA reagents and related typing solutions to transplant laboratories.

Emerging players

• TBG Diagnostics: TBG Diagnostics offers molecular diagnostics products including HLA typing services. It is a smaller player with partial overlap to GenDx's HLA typing portfolio, primarily in the Asia-Pacific region.
• Protrans: Protrans provides HLA typing reagents and cell therapy products for transplantation diagnostics. It has meaningful overlap with GenDx's HLA reagent portfolio in the European market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/gendxhla
• LinkedInlinkedin.com/company/gendx
• Instagraminstagram.com/gendx_hla
• Xx.com/GenDx_HLA

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genome Diagnostics